Actively Recruiting
Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers
Led by Institute of Oncology Ljubljana · Updated on 2024-10-17
20
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to determine the total concentration of selected trace elements (Cu, Zn, Fe), the proportion of free Cu and Cu bound to ceruloplasmin and the isotopic ratio of Cu65/Cu63 in blood serum samples from healthy volunteers and cancer patients using inductively coupled plasma mass spectrometry-based methods. The results will be statistically evaluated and the potential applications of the analytical methods used in cancer diagnosis and therapy will be assessed.
CONDITIONS
Official Title
Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Cytologically or histologically confirmed biliary tract cancer
- No previous systemic or radiation therapy for advanced, inoperable, or metastatic disease
- WHO performance status between 0 and 2 according to ECOG criteria
- Imaging diagnosis (CT scan of thoracic and abdominal organs) within 4 weeks before starting systemic therapy
- Disease measurable by RECIST or ECOG criteria
- Signed informed consent to participate in clinical research
You will not qualify if you...
- Previous systemic treatment or radiation therapy for inoperable or metastatic disease
- WHO performance status greater than 2 according to ECOG criteria
- Contraindications to immunotherapy, including known immunodeficiency, active immunosuppressive therapy, or active autoimmune disease requiring treatment
- Presence of other malignancies except for cured basal cell or squamous cell carcinoma of the skin, in situ carcinoma of the cervix, or other cured solid tumors without recurrence for at least 3 years after treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute of Oncology Ljubljana
Ljubljana, Slovenia
Actively Recruiting
Research Team
M
Martina Reberšek, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here